MD Anderson News Release 11/23/2015
Distinguished contributions to understanding p53 tumor suppression in stem cells and breakthrough advances in treating breast cancer have earned two scientists at The University of Texas MD Anderson Cancer Center membership in a notable association of scholars.
米歇尔·c·巴顿Ph.D., dean, The University of Texas Graduate School of Biomedical Sciences at Houston (GSBS) and...
MD Anderson News Release 11/20/2015
The University of Texas MD Anderson Cancer Center was awarded more than $22 million in research...
188bet体育网址研究使得微小RNA的情况下用于阻挡PDL1;在I期临床试验的相关药物
MD Anderson News Release 11/20/2015
<...
Company secures $80-plus million in committed funding to develop exosome-based therapeutic and diagnostic products
MD Anderson News Release 11/17/2015
Codiak BioSciences, Inc. announced today the closing of the first portion of a planned $80-plus million Series A and B financing. The company also executed license and sponsored research agreements with The University of Texas MD Anderson Cancer Center in Houston...
MD Anderson study sheds new light on monoclonal antibody therapy cetuximab
MD安德森新闻发布2015年11月16日
Cetuximab...
Andrew Sabin Fellowship Program aims to advance MD Anderson’s goal to end cancer
MD安德森新闻发布2015年11月16日
MD安德森新闻发布2015年11月11日
A study at The University of Texas MD Anderson Cancer Center may explain why chemotherapy...
Journalist Norah O’Donnell will interview Rice at dinner benefiting cancer research
MD Anderson News Release 11/09/2015
...
MD Anderson study also finds individuals with certain genetic variations more vulnerable to dietary risk
MD Anderson News Release...
Collaboration Combines Leading Research in Chimeric Antigen Receptor (CAR) Natural Killer (NK) Cell Therapies with CytomX’s Probody Platform...